Kara Cannon - 31 Aug 2023 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role
Chief Operating Officer
Signature
/s/ Kara Cannon
Issuer symbol
ENZB
Transactions as of
31 Aug 2023
Net transactions value
-$98,098
Form type
4
Filing time
05 Sep 2023, 21:35:30 UTC
Previous filing
31 Jan 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Award $0 +345,080 +2285% $0.000000 360,180 31 Aug 2023 Direct F1
transaction ENZ Common Stock, $0.01 Par Value Tax liability $98,098 -63,700 -18% $1.54 296,480 31 Aug 2023 Direct
holding ENZ Common Stock, $0.01 Par Value 33,160 31 Aug 2023 401k
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units ("RSUs") for no consideration as part of a transaction bonus pursuant to the Reporting Person's employment agreement with the Issuer. 129,870 of the RSUs will vest immediately and 215,210 of the RSUs will vest on July 24, 2024 subject to the Reporting Person's continued employment with the Issuer.